Mar 11, 2022, 14:08 PM by

Mar 11, 2022, 14:08 PM by

Mar 10, 2022, 01:00 AM by User Not Found

Bio-IT World | A new method to screen drugs for treating Alzheimer’s disease could significantly improve the odds of therapeutic success by analyzing causal mechanisms in human neurons, according to Shankar Subramaniam, professor of bioengineering at the University of California (UC) San Diego. The plan now is to extend the work to organoids with microglia cells and vasculature, creating “realistic human brain avatars” for better understanding disease endotypes and their response to treatment.

Mar 8, 2022, 01:00 AM by User Not Found

Bio-IT World | As Executive Director of Enterprise Data Engineering and Analytics at CVS Health, Saira Kazmi uses her background in computer science and engineering in both academic and industry positions to inform her new role. She learned about the importance of iterative testing under the tightest timelines from the industry and got a first-hand view of the engineering rigor required to enable bioinformatics from her academic career. Now she is focused on creating data assets and managing the data life cycle at the enterprise level for a major healthcare player.

Mar 7, 2022, 01:00 AM by User Not Found

Bio-IT World | An organoid model is being used to flush out what’s behind production of a rare subset of cells in the human intestine and the hormones they manufacture, including four that seem to have the most effect on decreasing appetite.

Mar 3, 2022, 01:00 AM by User Not Found

Bio-IT World | Our technical capabilities are becoming increasingly granular, and proteomics is no exception. At the recent Molecular & Precision Med TRI-CON, Christopher Rose reported on how his group within the Microchemistry, Proteomics & Lipidomics department at Genentech where he currently leads the Discovery Proteomics group is working to build a single-cell proteomics platform.

Mar 2, 2022, 15:01 PM by User Not Found

Bio-IT World | Structural variant detection in FFPE samples, new federated network for genomic variant surveillance, Element Biosciences’ new acquisitions and collaborations, RNA profiling to predict preterm birth, release of multi-modal mental health dataset, AI in genetic variant analysis for cancer and beta-propeller protein-associated neurodegeneration, and more.

Feb 28, 2022, 11:48 AM by User Not Found

Bio-IT World | AI and ML in immunological therapeutic development, virtual drug screening, microscope-based rapid pathogen diagnostics, improved genetic variant interpretation, and more.

Feb 25, 2022, 01:00 AM by User Not Found

Bio-IT World | The clock is ticking on implementing the EMA's IDMP standard. With the release of EU IG v2.1, the industry is in the final stages of preparations for optional submission. While regulatory teams have made progress applying guidance to uniquely identify products and standardize information, more work remains to establish a proper data foundation that supports submissions under the new requirements.

Feb 24, 2022, 01:00 AM by User Not Found

Bio-IT World | In the opening plenary panel for the Molecular and Precision Med Tri-Con this week, Robert Green, Brigham and Women’s Hospital, led a group in exploring how genomics, digital health, and more will converge to deliver precision health. He was joined by Megan Mahoney, Stanford University; Jessica Mega, Verily Life Sciences; Sir Mark Caulfield, Barts Life Sciences & Queen Mary University of London; and Lara Jehi, Cleveland Clinic.

Feb 23, 2022, 01:00 AM by User Not Found

Bio-IT World | At this week’s Molecular & Precision Medicine Tri-Con event, Simon Gregory, profession or neurology at the Duke University School of Medicine, outlined how his team has been using 10X Genomics’ Visium platform and Oxford Nanopore long read sequencing to understand the pathology of Alzheimer’s Disease development.

Feb 23, 2022, 01:00 AM by User Not Found

Bio-IT World | On the first morning of the Molecular & Precision Med Tri-Con event, Viktor Adalsteinsson, associate director of the Gerstner Center for Cancer Diagnostics at the Broad Institute, explored new tools and techniques for detecting minimal residual disease.

Feb 22, 2022, 15:27 PM by User Not Found

Bio-IT World | Bio-IT World and BioTeam have been exploring the drivers of life sciences innovation for years during the Bio-IT World Conference & Expo and in regular columns in the publication. Now, together, we’ve launched a new podcast to capture in-depth conversations with leaders in the field about data, culture, technology, and more.

Feb 18, 2022, 17:24 PM by

Feb 18, 2022, 17:24 PM by

Feb 18, 2022, 17:24 PM by

Bracknell, UK – 14th February 2022: mdgroup, a leading global medtech and patient health services company pioneering a patient-first approach to clinical research, has been named as one of the UK's fastest-scaling businesses in 2021's Organic Growth 25 (OG25) index in recognition of its major growth and success, without significant external investment.

Feb 18, 2022, 17:24 PM by

mdgroup Appoints Steph Katz as Director of Seacole Health Combining Passion for Nursing and Clinical Research to Provide Remarkable Patient Experiences Bracknell, UK: 15 February 2022 - mdgroup, the leading global provider of personalised clinical study services, has appointed Steph Katz as Director of business subsidiary Seacole Health. Seacole Health brings mdgroup’s mobile health and clinical research staff resourcing under one roof. Steph is the ideal person to lead this exciting new venture because of her wealth of healthcare knowledge. Having started as an oncology nurse in intensive care units, Steph achieved her MSN in Nursing Education and began training research coordinators, clinical nurses and fellows. She then took on a management role, helping to develop and operationalize institutional, federal and commercial clinical research projects before pursuing an MBA.

Feb 18, 2022, 17:24 PM by

AI-powered cloud software platform PubHive Navigator now features a new user dashboard that speeds up systematic literature review workflows for PubHive users

Feb 18, 2022, 17:24 PM by

Curebase, a company committed to democratizing access to clinical studies, has named Dr. Aaron Kamauu and Dr. Amir Lahav to the Curebase Advisory Board.

Feb 18, 2022, 17:24 PM by

Tesis Biosciences Acquires Genome Explorations to Accelerate Clinical Research and Product Development for Chronic Disease Cures